Hybrid-capture sequencing is the most effective way of sequencing gene mutations in lymphoid cancers, a study has shown. The study, published today in Nature Communications, shows that it can be done at low cost, and with high accuracy for many types of cancers. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. This, in turn, allows more precise diagnosis and treatment of those suffering from lymphoid cancer.
Hybrid-capture sequencing is the most effective way of sequencing gene mutations in lymphoid cancers, a study has shown. The study, published today in Nature Communications, shows that it can be done at low cost, and with high accuracy for many types of cancers. This, in turn, allows more precise diagnosis and treatment of those suffering from lymphoid cancer.